| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/13/2013 | CN101528239B Ophthalmic aqeous liquid preparation |
| 03/13/2013 | CN101513456B Chinese medicinal composition for treating headache, preparation method and quality control method thereof |
| 03/13/2013 | CN101513391B Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention |
| 03/13/2013 | CN101505714B Use of a composition for skin treatment under X-irradiation |
| 03/13/2013 | CN101439068B Chinese medicine granule containing silymarin and preparation method thereof |
| 03/13/2013 | CN101284133B Drug carried tumor-targeted cationic polymer for injections and modified by integrin ligand |
| 03/13/2013 | CN101272848B Method to improve characteristics of spray dried powders and granulated materials, and the products thereby produced |
| 03/13/2013 | CN101181354B Fructus schizandrae chemical composition group extract and preparation technique |
| 03/13/2013 | CN101035517B Tablets with site, time-controlled gastrointestinal release of active ingredient |
| 03/13/2013 | CA2789600A1 Composition for enhancing transdermal absorption of a drug and patch preparation |
| 03/13/2013 | CA2789572A1 Composition for enhancing transdermal absorption of a drug and patch preparation |
| 03/13/2013 | CA2789569A1 Composition for enhancing transdermal absorption of a drug and patch preparation |
| 03/12/2013 | US8395581 User interface for medical system comprising diary function with time change feature |
| 03/12/2013 | US8395037 Pharmaceutical compositions for treating/preventing motor organ diseases |
| 03/12/2013 | US8394812 Sustained release formulations of nalbuphine |
| 03/12/2013 | US8394497 Microencapsulated particles and process for manufacturing same |
| 03/12/2013 | US8394494 Antimicrobial substrates and uses thereof |
| 03/12/2013 | US8394488 A biodegradable stent with two different polymeric layers, an enzymatic degradation additive, and a buffering agent; controlled drug release between 1 day and 6 months with mass loss of the stent as well |
| 03/12/2013 | US8394416 One step process for preparing cross-linked poly(allylamine) polymers |
| 03/12/2013 | US8394415 Modified release analgesic suspensions |
| 03/12/2013 | US8394414 Synthetic biodegradable microparticles incorporating a therapeutic, prophylactic or diagnostic agent having a diameter of 0.5-10 microns and release the agent at a pH of 6.0 or greater |
| 03/12/2013 | US8394413 Spherical ferrite nanoparticles and method for producing the same |
| 03/12/2013 | US8394412 Ultra-violet radiation absorbing silicon particle nanoclusters |
| 03/12/2013 | US8394411 Papillomavirus pseudoviruses for detection and therapy of tumors |
| 03/12/2013 | US8394410 Soft polylactides |
| 03/12/2013 | US8394409 Controlled extended drug release technology |
| 03/12/2013 | US8394408 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
| 03/12/2013 | US8394407 Delayed release tablet with defined core geometry |
| 03/12/2013 | US8394406 Once daily formulations of tetracyclines |
| 03/12/2013 | US8394405 Once daily formulations of tetracyclines |
| 03/12/2013 | US8394399 Drug-enhanced adhesion prevention |
| 03/12/2013 | US8394393 System and method for the release of nitric oxide using nanoscale media |
| 03/12/2013 | US8394392 Antibacterial agent composed of silver-containing aluminum sulfate hydroxide particles and use thereof |
| 03/12/2013 | US8394391 Drug delivery vehicle that mimics viral properties |
| 03/12/2013 | US8394371 Compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same |
| 03/12/2013 | US8394361 Stable surfactant compositions for suspending components |
| 03/12/2013 | CA2572639C Compressed chewing gum tablet |
| 03/12/2013 | CA2571063C Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
| 03/12/2013 | CA2564234C Dermally applicable liquid formulations for controlling parasitic arthropods on animals |
| 03/12/2013 | CA2545877C Biodegradable colloidal particles for pulmonary applications in particular |
| 03/12/2013 | CA2537029C Micellar systems useful for delivery of lipophilic or hydrophobic compounds |
| 03/12/2013 | CA2533150C A doxycycline metal complex in a solid dosage form |
| 03/12/2013 | CA2505414C Lipophilic phosphoramide compounds and uses thereof |
| 03/12/2013 | CA2503383C Extended, controlled release pharmaceutical compositions comprising charged polymers |
| 03/12/2013 | CA2500310C Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
| 03/12/2013 | CA2473927C Methods and compositions for treating polycystic ovary syndrome |
| 03/12/2013 | CA2464092C Electroprocessing in drug delivery and cell encapsulation |
| 03/12/2013 | CA2437266C Taste-masked resinate and preparation thereof |
| 03/12/2013 | CA2366787C Compositions and methods for treating lymphoma |
| 03/07/2013 | WO2013033717A1 Enzyme responsive nanocapsules for protein delivery |
| 03/07/2013 | WO2013033662A1 Limited release lingual thioctic acid delivery systems |
| 03/07/2013 | WO2013033642A1 Formulations and dosage forms of oxidized phospholipids |
| 03/07/2013 | WO2013033563A1 Pegylated liposomes for delivery of immunogen-encoding rna |
| 03/07/2013 | WO2013033513A1 Apoptosis-targeting nanoparticles |
| 03/07/2013 | WO2013033400A2 Methods for effectively and rapidly desensitizing allergic patients |
| 03/07/2013 | WO2013033304A2 Capsule having broad color spectrum |
| 03/07/2013 | WO2013033194A1 Levothyroxine formulations |
| 03/07/2013 | WO2013033176A1 Decitabine derivative formulations |
| 03/07/2013 | WO2013032828A2 Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking |
| 03/07/2013 | WO2013032673A1 Coating composition comprising a cellulose ether and starch |
| 03/07/2013 | WO2013032643A2 Lipids capable of conformational change and their use in formulations to deliver therapeutic agents to cells |
| 03/07/2013 | WO2013032575A1 Cosmetic liquid extractor comprising nonionic polymers |
| 03/07/2013 | WO2013032310A1 Fast-dissolving megestrol tablet and method for preparing same |
| 03/07/2013 | WO2013032248A2 Composition for improving skin conditions, containing extracellular domain of human bone morphogenetic protein receptor 1a as active ingredient |
| 03/07/2013 | WO2013032207A1 Sustained-release lipid pre-concentrate of pharmacologically active substance and pharmaceutical composition comprising the same |
| 03/07/2013 | WO2013032206A1 Controlled-release oral composition containing itopride hydrochloride, and preparation method thereof |
| 03/07/2013 | WO2013032185A1 Extended release preparation containing pregabalin |
| 03/07/2013 | WO2013031992A1 Adhesive patch |
| 03/07/2013 | WO2013031972A1 Pump unit of capsule manufacturing apparatus for supplying capsule liquid, capsule manufacturing apparatus applying the pump unit, method for capsule manufacturing applying same, capsule manufactured by same |
| 03/07/2013 | WO2013031949A1 Soft capsule pharmaceutical preparation, composition for soft capsule pharmaceutical preparation, and method for producing soft capsule pharmaceutical preparation |
| 03/07/2013 | WO2013031935A1 Stable pharmaceutical composition |
| 03/07/2013 | WO2013031833A1 Skin introduction system and lightening agent combining cell introduction peptide and skin introduction accelerator |
| 03/07/2013 | WO2013030789A1 Pharmaceutical oral solid dosage form containing a poorly water soluble pde - iv inhibitor |
| 03/07/2013 | WO2013030726A1 Programmed drug delivery |
| 03/07/2013 | WO2013030602A1 Solid extended release composition for oral administration comprising substantially amorphous capecitabine |
| 03/07/2013 | WO2013030547A1 Dispenser |
| 03/07/2013 | WO2013030348A1 Oral formulations containing hyaluronic acid for sustained drug release |
| 03/07/2013 | WO2013030299A1 Method for enhancing the thermal stability of ionic compounds |
| 03/07/2013 | WO2013030267A1 Multi-layered release formulation |
| 03/07/2013 | WO2013030240A1 Phase transfer reactions |
| 03/07/2013 | WO2013030177A1 Abuse resistant tablet comprising oxycodone and paracetamol |
| 03/07/2013 | WO2013030129A1 Transdermal therapeutic system for 5-aminolevulinic acid hydrochloride |
| 03/07/2013 | WO2013030119A1 Dosage form having stabilized active-ingredient particles |
| 03/07/2013 | WO2013029525A1 Pharmaceutical composition comprising iodine polymer and glucocorticosteroid for treating dermatitis |
| 03/07/2013 | WO2013029297A1 Use of patchouli alcohol in preparation of drug against helicobacter pylori |
| 03/07/2013 | WO2013029198A1 Adefovir dipivoxil solid formulation and preparation method therefor |
| 03/07/2013 | WO2013029194A1 Use of non-steroidal anti-inflammatory drugs meloxicam and piroxicam, administered intravaginally, for interruption of a woman's ovulation process |
| 03/07/2013 | WO2013029139A1 Fluorescent polyaniline nanoparticles |
| 03/07/2013 | WO2013010137A3 A composition, device and method for delayed and sustained release of brain energy molecules |
| 03/07/2013 | WO2013009009A3 Film comprising poly octylcyanoacrylate for preventing tissue adhesion and method for manufacturing same |
| 03/07/2013 | WO2013008253A3 Imatinib formulations |
| 03/07/2013 | WO2013008240A8 Liposomes co-encapsulating a bisphosphonate and an amphipathic agent |
| 03/07/2013 | WO2012169736A3 Patch for transdermal delivery of composition and manufacturing method thereof |
| 03/07/2013 | WO2012163501A9 Nasal pharmaceutical formulation |
| 03/07/2013 | WO2012160333A3 Recombinant yeast expressing human h- ferritin |
| 03/07/2013 | WO2012159593A9 A combined oral formulation with controlled release of acetylsalicylic acid and a method for the preparation |
| 03/07/2013 | WO2012158127A3 Water-soluble formulations comprising dexketoprofen |
| 03/07/2013 | WO2012103038A9 Nanoparticle compositions, formulations thereof, and uses therefor |
| 03/07/2013 | WO2012057895A9 Composition and method for treating wounds |
| 03/07/2013 | WO2011146852A8 Foams or particles for applications such as drug delivery |